EXTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq:IDRA) today reported its financial and operational results for the first quarter ended March 31, 2022.
Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Globe Newswire - Press Release 
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
